Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Roman Camarda(University of California, San Francisco), Andrei Goga(University of California, San Francisco), Henok Eyob(University of California, San Francisco), Daniel K. Nomura(Berkeley College), Rebecca A. Kohnz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Céline I. Mahieu(University of California, San Francisco), Sanjeev Balakrishnan(University of California, San Francisco), Alicia Y. Zhou(Whitehead Institute for Biomedical Research), Shingo Kajimura(Hadassah Medical Center), Brittany Anderton(Gladstone Institutes), Gregor Krings(Cleveland Clinic), Aaron D. Tward(Eli Lilly (United States))
Cited by 539
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
Advances in covalent drug discovery
|Nature Reviews Drug Discovery|2022|757
Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis
|Journal of Clinical Investigation|2015|685